[ad_1]
© Reuters. FILE PHOTO: Nivea tins are seen on a production line at the plant of German personal care company Beiersdorf in Hamburg, Germany, March 3, 2017. REUTERS/Fabian Bimmer/File Photo
(Reuters) – Beiersdorf said on Friday it had acquired a majority stake in Belgian biotechnology company S-Biomedic NV.
S Biomedic is to continue operating on its own under Beiersdorf’s existing microbiome programme, Beiersdorf added in a statement.
The purchase price was not disclosed.
[ad_2]
Image and article originally from www.investing.com. Read the original article here.